Anaheim, Calif.—Choosing the best an-ticoagulation strategy can be extremely challenging, especially when patients have diverse conditions requiring potentially different therapeutic approaches to atrial fibrillation, thrombosis and stroke prevention, and limited data are available on the newer anticoagulants.
“We have to make decisions based on the information we have, even though sometimes it isn’t the greatest information,” said Paul P. Dobesh, PharmD,